In the last 40 years, advances in protein engineering and evolution have prompted the application of biocatalysts in the synthesis of active pharmaceutical ingredients (API), as well as fine and bulk chemicals for the agrochemical, food, biofuel, and pharmaceutical industries. Computational chemistry methodologies in conjunction with smart variant library generation and high-throughput screening are fueling the development of a new generation of rationally designed biocatalysts with enhanced selectivity and specificity at a fraction of the time and cost of what was achievable a mere decade ago.

合成生物学分野では、無細胞タンパク質の発現により発見を加速させることが可能です。Gene Fragments は無細胞タンパク質の発現に最適なツールです。

大量の人工 DNA を入手できるようになったことで、Ginkgo Bioworks における設計・構築・テスト・学習のサイクルが変化